![Timothy Kelly](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Timothy Kelly
Technik-/Wissenschafts-/F&E-Leiter bei
CARIBOU BIOSCIENCES, INC.
Vermögen: 128 700 $ am 30.06.2026
Profil
Timothy P.
Kelly is currently Chief Technology Officer at Caribou Biosciences, Inc. since 2024.
Formerly, Mr. Kelly was Chairman & Chief Executive Officer at Oxford Biomedica Solutions LLC from 2022 to 2023; Chief Operating Officer at Homology Medicines, Inc. from 2021 to 2022; Head-Technical Operations at Sarepta Therapeutics, Inc. in 2017; Senior Vice President & Head-Biologics Operating at Shire Plc from 2016 to 2017; Head-Technical Operations at UCB SA from 2005 to 2009; Senior Director-International Operations at Biogen, Inc. from 1998 to 2005.
Education includes undergraduate studies at the United States Air Force Academy and an MBA from Troy University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 25.02.2026 | 73.125 ( 0,07 % ) | 128 700 $ | 30.06.2026 |
Aktive Positionen von Timothy Kelly
| Unternehmen | Position | Beginn |
|---|---|---|
| CARIBOU BIOSCIENCES, INC. | Technik-/Wissenschafts-/F&E-Leiter | 07.01.2024 |
Ehemalige bekannte Positionen von Timothy Kelly
| Unternehmen | Position | Ende |
|---|---|---|
Oxford Biomedica Solutions LLC
 Oxford Biomedica Solutions LLC Industrial MachineryProducer Manufacturing Operates as an AAV focused manufacturing and innovation company | Vorstandsvorsitzender | 01.07.2023 |
| Q32 BIO INC. | Geschäftsführer | 10.03.2022 |
| SAREPTA THERAPEUTICS, INC. | Corporate Officer/Principal | 01.05.2017 |
| SHIRE | Corporate Officer/Principal | 01.01.2017 |
| UCB | Corporate Officer/Principal | 01.01.2009 |
Ausbildung von Timothy Kelly
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
71
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Sarepta Therapeutics, Inc.
 Sarepta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures micro-dystrophin gene therapy | Health Technology |
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Develops and markets medicines for patients with rare diseases | Health Technology |
Caribou Biosciences, Inc.
 Caribou Biosciences, Inc. BiotechnologyHealth Technology Develops technology-based solutions for cellular engineering and analysis | Health Technology |
UCB SA
 UCB SA Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Health Technology |
United States Air Force Academy
 United States Air Force Academy Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Troy University
 Troy University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Homology Medicines, Inc.
 Homology Medicines, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage genetic medicines company | Health Technology |
Oxford Biomedica Solutions LLC
Oxford Biomedica Solutions LLC Industrial MachineryProducer Manufacturing Operates as an AAV focused manufacturing and innovation company | Producer Manufacturing |
Wählen Sie MarketScreener 
